The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial.Ruicci KM, Barry A, Ye XY, et al. Radiother Oncol. 2025 Jul 8:111041. DOI: 10.1016/j.radonc.2025.111041. Epub ahead of print. PMID: 40639764. 【背景と目的】・遠隔…